Search hospitals > South Carolina > Gaffney
Gibbs Cancer Center-Gaffney
Claim this profileGaffney, South Carolina 29341
Global Leader in Thyroid Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Uterine Tumors
110 reported clinical trials
12 medical researchers
Summary
Gibbs Cancer Center-Gaffney is a medical facility located in Gaffney, South Carolina. This center is recognized for care of Thyroid Cancer, Breast Cancer, Lung Cancer, Breast cancer, Uterine Tumors and other specialties. Gibbs Cancer Center-Gaffney is involved with conducting 110 clinical trials across 281 conditions. There are 12 research doctors associated with this hospital, such as Michael Humeniuk, Amarinthia (Amy) Curtis, Vikas Dembla, and Jeremy M. Kilburn.Area of expertise
1Thyroid Cancer
Global LeaderStage I
Stage IV
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Michael HumeniukSpartanburg Medical Center8 years of reported clinical research
Studies Thyroid Cancer
Studies Uterine Tumors
22 reported clinical trials
40 drugs studied
Amarinthia (Amy) CurtisSpartanburg Medical Center7 years of reported clinical research
Studies Thyroid Cancer
Studies Breast Cancer
17 reported clinical trials
37 drugs studied
Vikas DemblaSpartanburg Medical Center5 years of reported clinical research
Studies Thyroid Cancer
Studies Colorectal Cancer
12 reported clinical trials
27 drugs studied
Jeremy M. KilburnGibbs Cancer Center-Pelham5 years of reported clinical research
Studies Lung Cancer
Studies Uterine Tumors
8 reported clinical trials
21 drugs studied
Clinical Trials running at Gibbs Cancer Center-Gaffney
Breast Cancer
Lung Cancer
Thyroid Cancer
Bladder Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Testicular cancer
Breast cancer
Cutaneous Melanoma
Uterine Tumors
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Gibbs Cancer Center-Gaffney?
Gibbs Cancer Center-Gaffney is a medical facility located in Gaffney, South Carolina. This center is recognized for care of Thyroid Cancer, Breast Cancer, Lung Cancer, Breast cancer, Uterine Tumors and other specialties. Gibbs Cancer Center-Gaffney is involved with conducting 110 clinical trials across 281 conditions. There are 12 research doctors associated with this hospital, such as Michael Humeniuk, Amarinthia (Amy) Curtis, Vikas Dembla, and Jeremy M. Kilburn.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.